Board Meeting14 Aug 2026, 04:01 pm
Genomic Valley Biotech declares standalone un-audited results
AI Summary
Genomic Valley Biotech Ltd announced that its Board of Directors has considered and approved the standalone un-audited financial results for the quarter ended June 30, 2026. The board meeting took place on August 14, 2026. A limited review report from the statutory auditor is enclosed with the results. The company's registered office is located in Haryana, and the corporate office is in Delhi.
Key Highlights
- Board approved standalone un-audited financial results.
- Results are for the quarter ended June 30, 2026.
- Board meeting held on August 14, 2026.
- Limited review report from auditor is attached.
Price Impact
More from GVBL